LncRNA GAS5 inhibits NLRP3 inflammasome activation-mediated pyroptosis in diabetic cardiomyopathy by targeting miR-34b-3p/AHR

References

• Hayat SP, Khattar R. Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin Sci. 2004;107:539–557.
   PubMed Web of Science ®Google Scholar
• Gulsin GS, Athithan L, McCann GP. Diabetic cardiomyopathy: prevalence, determinants and potential treatments. Ther Adv Endocrinol Metab. 2019;10:2042018819834869.
   Web of Science ®Google Scholar
• Galderisi M. Diastolic dysfunction and diabetic cardiomyopathy: evaluation by Doppler echocardiography. J Am Coll Cardiol. 2006;48:1548–1551.
   PubMed Web of Science ®Google Scholar
• Cosson SKJP. Left ventricular diastolic dysfunction: an early sign of diabetic cardiomyopathy? Diabetes Metab. 2003;29:455–466.
   PubMed Web of Science ®Google Scholar
• Okruhlicova L, Weismann P. Ultrastructure and histochemistry of rat myocardial capillary endothelial cells in response to diabetes and hypertension. Cell Res. 2005;15:532–538.
   PubMed Web of Science ®Google Scholar
• Luo B, Huang F, Liu Y, et al. NLRP3 Inflammasome as a molecular marker in diabetic cardiomyopathy. Front Physiol. 2017;8:519.
   PubMed Web of Science ®Google Scholar
• Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell. 2002;10:417–426.
   PubMed Web of Science ®Google Scholar
• Shi J, Zhao Y, Wang K, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015;526:660–665.
   PubMed Web of Science ®Google Scholar
• He WT, Wan H, Hu L, et al. Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion. Cell Res. 2015;25:1285–1298.
   PubMed Web of Science ®Google Scholar
• Kayagaki N, Stowe I, Lee BL, et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature. 2015;526:666–671.
   PubMed Web of Science ®Google Scholar
• Zhang H, Chen X, Zong B, et al. Gypenosides improve diabetic cardiomyopathy by inhibiting ROS-mediated NLRP3 inflammasome activation. J Cell Mol Med. 2018;22:4437–4448.
   PubMed Web of Science ®Google Scholar
• Yang F, Qin Y, Wang Y, et al. Metformin Inhibits the NLRP3 Inflammasome via AMPK/mTOR-dependent Effects in Diabetic Cardiomyopathy. Int J Biol Sci. 2019;15:1010–1019.
   PubMed Web of Science ®Google Scholar
• Luo B, Li B, Wang W, et al. NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model. PloS One. 2014;9:e104771.
   PubMed Web of Science ®Google Scholar
• Liu HL, Chen CH, Sun YJ. Overexpression of lncRNA GAS5 attenuates cardiac fibrosis through regulating PTEN/MMP-2 signal pathway in mice. Eur Rev Med Pharmacol Sci. 2019;23:4414–4418.
   PubMed Web of Science ®Google Scholar
• Li X, Hou L, Cheng Z, et al. Overexpression of GAS5 inhibits abnormal activation of Wnt/beta-catenin signaling pathway in myocardial tissues of rats with coronary artery disease. J Cell Physiol. 2019;234:11348–11359.
   PubMed Web of Science ®Google Scholar
• Du J, Yang ST, Liu J, et al. Silence of LncRNA GAS5 Protects Cardiomyocytes H9c2 against Hypoxic Injury via Sponging miR-142-5p. Mol Cells. 2019;42:397–405.
   PubMed Web of Science ®Google Scholar
• Pant T, Mishra MK, Bai X, et al. Microarray analysis of long non-coding RNA and mRNA expression profiles in diabetic cardiomyopathy using human induced pluripotent stem cell-derived cardiomyocytes. Diab Vasc Dis Res. 2019;16:57–68.
   PubMed Web of Science ®Google Scholar
• Huai W, Zhao R, Song H, et al. Aryl hydrocarbon receptor negatively regulates NLRP3 inflammasome activity by inhibiting NLRP3 transcription. Nat Commun. 2014;5:4738.
   PubMed Web of Science ®Google Scholar
• Li Y, Li Y, Huang S. Long non-coding RNA growth arrest specific transcript 5 acts as a tumour suppressor in colorectal cancer by inhibiting interleukin-10 and vascular endothelial growth factor expression. Oncotarget. 2017;8:13690–13702.
   PubMedGoogle Scholar
• Li J, Yang C, Li Y, et al. LncRNA GAS5 suppresses ovarian cancer by inducing inflammasome formation. Biosci Rep. 2017;38: BSR20171150.
   Web of Science ®Google Scholar
• Carter G, Miladinovic B, Patel AA, et al. Circulating long noncoding RNA GAS5 levels are correlated to prevalence of type 2 diabetes mellitus. BBA Clin. 2015;4:102–107.
   PubMed Web of Science ®Google Scholar
• Feng H, Ge F, Du L, et al. MiR-34b-3p represses cell proliferation, cell cycle progression and cell apoptosis in non-small-cell lung cancer (NSCLC) by targeting CDK4. J Cell Mol Med. 2019;23:5282–5291.
   PubMed Web of Science ®Google Scholar
• Mizuno K, Mataki H, Arai T, et al. The microRNA expression signature of small cell lung cancer: tumor suppressors of miR-27a-5p and miR-34b-3p and their targeted oncogenes. J Hum Genet. 2017;62:671–678.
   PubMed Web of Science ®Google Scholar
• Cordova-Rivas S, Fraire-Soto I, Mercado-Casas Torres A, et al. 5p and 3p strands of miR-34 family members have differential effects in cell proliferation, migration, and invasion in cervical cancer cells. Int J Mol Sci. 2019;20:545.
   PubMedGoogle Scholar
• Xie C, Wu W, Tang A, et al. lncRNA GAS5/miR-452-5p reduces oxidative stress and pyroptosis of high-glucose-stimulated renal tubular cells. Diabetes metabolic syndrome obesity. 2019;12:2609–2617.
   PubMed Web of Science ®Google Scholar
• Lv L, Li D, Tian F, et al. Silence of lncRNA GAS5 alleviates high glucose toxicity to human renal tubular epithelial HK-2 cells through regulation of miR-27a. Artif Cells Nanomed Biotechnol. 2019;47:2205–2212.
   PubMed Web of Science ®Google Scholar
• Zhao JL, Li C. Knockdown of long noncoding RNA GAS5 protects human cardiomyocyte-like AC16 cells against high glucose-induced inflammation by inhibiting miR-21-5p-mediated TLR4/NF-κB signaling. Naunyn-Schmiedeberg’s Arch Pharmacol. 2019;393:1541-1547.
   Google Scholar
• Shen Y, Jin X, Chen W, et al. Interleukin-22 ameliorated acetaminophen-induced kidney injury by inhibiting mitochondrial dysfunction and inflammatory responses. Appl Microbiol Biotechnol. 2020;104:5889–5898.
   PubMed Web of Science ®Google Scholar
• Zeng C, Duan F, Hu J, et al. NLRP3 inflammasome-mediated pyroptosis contributes to the pathogenesis of non-ischemic dilated cardiomyopathy. Redox Biol. 2020;34:101523.
   PubMed Web of Science ®Google Scholar
• Chang Y, Zhu J, Wang D, et al. NLRP3 inflammasome-mediated microglial pyroptosis is critically involved in the development of post-cardiac arrest brain injury. J Neuroinflammation. 2020;17:219.
   PubMed Web of Science ®Google Scholar